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Abstract
Background: Cardiac troponin assays have improved the ability to detect myocardial damage. However,
ascertaining whether troponin elevation is due to myocardial infarction (MI) or secondary to another process can
be challenging. Our aim is to evaluate provider-level variation in the diagnosis of MI and the use of invasive
coronary angiography (ICA) among patients with undifferentiated elevations in cardiac troponin.
Methods: We analyzed data from all patients with elevated troponin levels in a single Veterans Affairs (VA) Medical
Center between 2006 and 2007. One of several cardiologists prospectively evaluated each patient’s presentation
and course of care. We compared the frequency of MI diagnosis and ICA use between physicians using univariate
odds ratios (OR).
Results: Among 761 patients, 34.0 % were diagnosed with MI and 25.9 % underwent ICA. The unadjusted rates of
MI (23.9 to 56.7 %, P = 0.02) and ICA (17.3 to 73.3 %, P < 0.001) differed between physicians. Comparing the patient
cohorts for each physician, baseline characteristics were similar except for chest pain. In multivariate regression,
factors associated with the use of cardiac ICA included an abnormal electrocardiograph (ECG) (OR = 1.89, P = 0.014),
level of troponin (OR = 1.71, P = 0.004), chest pain (OR = 8.60, P < 0.001), and care by non-VA physicians (OR = 4.
45, P = 0.006). One physician had a lower ICA use (OR = 0.56, P = 0.017). In multivariate regression of MI, no
physician-level variation was observed.
Conclusion: Among patients with elevated troponin, the likelihood of being diagnosed with MI and
undergoing ICA is dependent on their clinical presentation. After adjustment, physician-level variation in care
was observed for the use of ICA, but not for the diagnosis of MI.
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Background
Cardiac troponin (Tn) is a sensitive marker of myocar-
dial necrosis [1], but Tn can be elevated in many disease
states without clinical evidence of myocardial infarction
(MI) [2, 3]. The universal definition of myocardial infarc-
tion is a rise and/or fall of a cardiac biomarker,
preferably Tn, in addition to a clinical presentation con-
sistent with MI [4]. Despite this, physicians may disagree
when applying this definition to individual patients.
Accurate clinical diagnosis of MI is important to guide
appropriate utilization of diagnostic procedures and risk
modifying therapies.
Variation in the use of medical testing and the inter-
pretation of a diagnostic test is well documented in the
medical literature and extends to the level of the individ-
ual provider [5, 6]. The use of cardiac testing and the in-
terpretation of cardiac tests is also subject to significant
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variation [7–9]. Indeed, there is approximately a 2-fold
regional variation in the use of invasive coronary angiog-
raphy (ICA) after acute myocardial infarction within the
United States [10, 11].
As part of a local quality improvement effort, our facil-
ity tracked all patients with elevated Tn for a one-year
period. This provided a unique opportunity to evaluate
patterns of MI diagnosis and the use of ICA in response
to elevated Tn. We analyzed that database to determine
if the care of patients with elevated Tn differed among
providers.
Methods
We conducted a single center retrospective cohort study
at our Veterans Affairs (VA) Medical Center. Data were
obtained from a quality improvement program con-
ducted on patients with elevated Tn who were seen in
our facility between February 2006 and February 2007.
The study protocol was reviewed by the Institutional Re-
view Board-01 Gainesville Health Science Center, and
the requirement for informed consent was waived. Dur-
ing that time frame, a “troponin team” evaluated every
patient with an elevated Tn, defined as being greater
than 0.03 ng/ml on our Tn-T assay. The team was led by
a clinical coordinator who received a daily list from the
facility’s core laboratory of all patients who had an ele-
vated Tn. This coordinator evaluated each patient based
on their chart documentation and presented all patients
to a cardiologist who determined if the patient’s presen-
tation was consistent with a MI and whether ICA should
be performed. No formal definition of MI was applied,
and physicians were free to make the diagnosis based on
their clinical assessment of the patient. Because our fa-
cility does not have an inpatient service led by a cardi-
ologist, all other care decisions were left to the
admitting team with input from the cardiology consult-
ation service. Several cardiologists shared responsibility
for oversight of the “troponin team” including general/
noninvasive, interventional, and electrophysiology cardi-
ologists. Data were blinded as to the physician, and
therefore could not be analyzed at the level of subspe-
cialty within cardiology. Data, including each patient’s
baseline clinical characteristics, clinical course, thromb-
olysis in myocardial infarction (TIMI) score, electrocar-
diogram (ECG) results, and follow-up, were recorded by
the clinical coordinator.
The co-primary outcomes were the rates of MI diag-
nosis and ICA use between individual physicians, which
were compared using chi square analysis. We conducted
a multivariate logistic regression to determine how the
diagnosis of MI and the use of ICA were affected by the
following variables: age by year, sex, coronary artery dis-
ease, hypertension, diabetes mellitus, hyperlipidemia,
prior coronary intervention, prior coronary bypass
surgery, ECG changes, new ECG changes, primary
symptom of chest pain / dyspnea / other, serum creatin-
ine, level of 1st Tn measurement. Each physician was in-
cluded as an independent variable with the remainder of
the physicians for comparison. We considered attempt-
ing an additional hierarchical multi-level model to com-
pare odds ratios for MI diagnosis and ICA use between
physicians after accounting for clustering of patients
within their physician-based cohort. Due to the small
sample sizes, however, this model was not considered
statistically valid [12–14]. Odds ratios (OR) and 95 %
confidence intervals (CI) were reported. Because we
used an existing dataset, no formal a priori power calcu-
lation was performed. Baseline variables were compared
by parametric and nonparametric tests as appropriate.
Analysis was performed using SPSS version 21 (IBM,
Armonk, NY).
Results
A total of 761 patients were included. Patient character-
istics and their clinical course were compared between
the different physicians. Occasionally (i.e., weekends and
holidays) inpatient services were provided by physicians
from our affiliated academic medical center. Patients
seen by these physicians were grouped under “non-VA
Physician” (Table 1). While not randomly assigned, pa-
tient characteristics of the cohorts seen by each of the
physicians were similar, except for chest pain (P<0.01).
MI was diagnosed in 34.0 % of patients with positive Tn
and in 25.9 % patients who underwent ICA. The rates of
diagnosing MI (P = 0.02) and ICA use (P < 0.0001) dif-
fered between physicians, ranging from 23.9 to 56.7 %
and 17.3 to 73.3 %, respectively (Figs. 1 and 2).
Multivariate regression for the diagnosis of MI was
associated with the 1st Tn level (OR = 11.44, 95 % CI
4.60-28.48, P < 0.0001), chest pain (OR = 4.25, 95 % CI
2.84–6.37, P < 0.0001), and new ECG changes (OR =
3.88, 95 % CI 2.34–6.43, P < 0.0001). Creatinine was
associated with a lower likelihood of MI diagnosis
(OR = 0.68, 95 % CI 0.57–0.81, P < 0.0001) (Table 2).
None of the physicians were independently associated
with the diagnosis of MI. In multivariate regression,
cardiac ICA was associated with several factors (Table
3), including chest pain (OR = 8.60, 95 % CI 5.2–14.2,
P < 0.0001), thrombolysis in myocardial infarction
(TIMI) score greater than 2 (OR = 3.27, 95 % CI
1.64–6.52, P = 0.001), abnormal ECG (OR = 1.89, 95 %
CI 1.13–3.13, P = 0.014), and the 1st Tn level (OR =
1.71, 95 % CI 1.19–2.47, P = 0.004). Increasing creatin-
ine levels were associated with a lower likelihood of ICA
(OR = 0.70, 95 % CI 0.58–0.85, P < 0.0001). Physician 2
was associated with a lower likelihood of ICA (OR = 0.56,
95 % CI 0.34–0.90, P = 0.017), while care by a non-VA
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physician was more likely to result in ICA (OR = 4.45,
95 % CI 1.54–12.89, P = 0.006).
Discussion
In this investigation, we demonstrated that the diagnosis
of MI and the use of ICA vary by individual cardiology
physicians within a single facility. After adjusting for dif-
ferences in patient characteristics, physician-level vari-
ation in ICA use persisted. Because this was not a
randomized trial and our sample size of providers was
not adequate for hierarchical modeling, we cannot be
certain that the observed variation was due to differ-
ences in the patient panel or to clinical decisions made
by individual providers. For example, the non-VA phys-
ician category saw more patients with chest pain, a
strong predictor of ICA use. Conversely, in our logistic
regression model, we did not observe any differences be-
tween individual physicians with regard to the diagnosis
of MI. While no formal definition of MI was applied,
this would suggest that our physicians did use similar
diagnostic criteria.
The overall rate of MI diagnosis Dx (34.0 %) and the
use of ICA (25.9 %) were both low in this population
despite the high risk of cardiovascular events. Approxi-
mately half the patients had prior CAD and diabetes,
and a substantial majority had TIMI scores greater than
2. This observation is due, at least in part, to what ap-
pears to be widespread use among patients without typ-
ical symptoms of MI. Our observed rate of MI was even
lower than the rate observed by Alcalai et al. [15]. We
















Male 100.0 98.7 99.1 99.3 100.0 98.5 100.0 0.940
CAD 55.2 47.3 53.2 57.5 42.1 41.8 56.7 0.210
Hypertension 86.2 75.2 77.1 81.3 77.2 65.7 80.0 0.230
Diabetes 51.7 43.8 44.5 41.0 45.6 47.8 50.0 0.920
Hyperlipidemia 48.3 57.1 56.4 58.2 63.2 55.2 70.0 0.680
Smoking 10.3 10.2 8.3 11.2 3.5 7.5 23.3 0.110
Chest pain 27.6 23.5 32.1 22.4 29.8 19.4 53.3 0.005
Dyspnea 20.7 26.1 21.6 29.9 28.1 19.4 13.3 0.320
Abnormal ECG 31 % 18.1 16.5 13.4 19.3 14.9 26.7 0.270
New ECG changes 27.6 15.9 12.4 13.4 19.3 13.4 30.0 0.090
TIMI score >2 82.8 80.8 81.5 83.5 73.7 72.7 88.0 0.410
MI diagnosed 37.9 28.8 38.5 33.6 36.8 23.9 56.7 0.020
ICA done 27.6 17.3 29.8 25.4 28.1 19.4 73.3 <0.001
CAD Coronary artery disease, ECG Electrocardiogram, ICA Invasive coronary angiography, MI Myocardial infarction, TIMI Thrombolysis myocardial infarction
Fig. 1 Difference in use of invasive coronary angiography between
different physicians. Height of each bar represents the proportion
patients with elevated troponin seen by a given provider (X axis)
whose treatment plan included invasive coronary angiography
Fig. 2 Difference in diagnosis of myocardial infarction between
different physicians. Height of each bar represents the proportion of
patients with elevated troponin seen by a given provider (X axis)
whose diagnosis was myocardial infarction
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cannot accurately ascertain the reasons for this observa-
tion from our database. Given the high proportion of pre-
existing CAD, type 2 myocardial infarctions or chronic,
baseline elevation in Tn are plausible explanations. We did
note in our logistic regression that an increased creatinine
was associated with lower likelihood of both MI and ICA.
Presumably, our physicians included elevated creatinine in
their consideration of whether Tn elevation was due to
MI. This also likely played a role in decisions concerning
ICA use where consideration for avoiding iodinated con-
trast and preserving renal function are important factors.
In our analysis of ICA use, physician-level variation
persisted within our regression model. One VA physician
was associated with a lower likelihood of ICA perhaps
reflecting a more conservative approach to MI manage-
ment. The non-VA physician group had a higher pro-
pensity for ICA. This group was comprised of multiple
physicians who do not practice regularly at our VA facility.
We cannot determine if the difference in ICA use repre-
sents overuse by the non-VA physicians or underuse by
those working at the VA. It is possible that the non-VA
physicians, unfamiliar with a veteran population, felt that
a more aggressive/invasive management strategy was
warranted. VA physicians appeared to have similar rates of
ICA use although this could represent widespread
underuse.
The landscape of cardiology practice has changed sub-
stantially since the data for this investigation were first
collected. The “troponin team” that once existed at our
institution is no longer in use. The primary reason for
its discontinuation was the high cost of the program
(which involved tracking all patients with an elevated Tn
and physician staffing). Furthermore, patient care was
not substantially improved (i.e., short-term mortality
tracked in the facility was not changed with the use of
the troponin team). We no longer have physicians who
share part-time staffing duties. All physicians are now
full-time VA employees. As such, we do not have any
immediate plans to alter our patterns of care based on
the results of our investigation.
Our data were gathered as part of a clinical demon-
stration project and not primarily as a research investi-
gation. As a result, definitions of MI and decisions to
perform ICA were not standardized. Patients were not
randomly assigned, and residual differences in patient
populations after logistic regression may have occurred.
A multi-level model controlling for patient characteris-
tics within each physician cohort would have been a
preferable statistical approach; however, our sample of
physicians was too small for this to be a valid approach.
This limited sample size and the blinding of the iden-
tities of individual physicians precludes any analysis
based on subspecialty within cardiology. The strongest
variation by an “individual physician” in our investiga-
tion was actually the group of non-VA physicians with
too few encounters to analyze individually, limiting the
ability to compare our data with other investigations of
individual physician care variations.
Conclusion
The likelihood of a patient with an elevated Tn being
diagnosed with MI and undergoing ICA is dependent on
their clinical presentation and may possibly depend on
the responsible physician. Whether this variation repre-
sents overuse or underuse is unclear.
Table 2 Logistic regression showing variables associated with diagnosis of MI
Variable β S.E. Wald P OR 95 % CI
1st troponin level 2.437 0.465 27.426 <0.0001 11.44 4.60 28.48
Chest Pain 1.447 0.206 49.102 <0.0001 4.25 2.84 6.37
New ECG changes 1.356 0.258 27.675 <0.0001 3.88 2.34 6.43
Smoker 1.249 0.322 15.023 <0.0001 3.49 1.85 6.56
TIMI score > 2 1.248 0.298 17.579 <0.0001 3.48 1.94 6.25
Creatinine −0.390 0.088 19.476 <0.0001 0.68 0.57 0.81
Constant −2.247 0.323 48.451 <0.0001 0.106
CI Confidence interval, ECG Electrocardiogram, OR Odds ratio, SE Standard error, TIMI Thrombolysis in myocardial infarction
Table 3 Logistic regression of variables associated with use of
cardiac catheterization
Variable β S.E. Wald P OR 95 % CI
Chest Pain 2.152 0.257 70.079 <0.0001 8.60 5.20 14.23
Non-VA physician 1.493 0.543 7.563 0.006 4.45 1.54 12.89
TIMI > 2 1.185 0.352 11.317 0.001 3.27 1.64 6.52
Smoker 0.854 0.334 6.543 0.011 2.35 1.22 4.52
Abnormal ECG 0.634 0.259 5.986 0.014 1.89 1.13 3.13
Dyspnea 0.582 0.290 4.028 0.045 1.79 1.01 3.16
1st troponin level 0.539 0.185 8.441 0.004 1.71 1.19 2.47
Age (by year) −0.031 0.011 8.780 0.003 0.97 0.95 0.99
Creatinine −0.352 0.097 13.276 <0.0001 0.70 0.58 0.85
Physician 2 −0.590 0.248 5.654 0.017 0.56 0.34 0.90
Constant −0.500 0.801 0.389 0.533 0.607
CI Confidence interval, ECG Electrocardiogram, OR Odds ratio, SE Standard
error, TIMI Thrombolysis in myocardial infarction
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